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Abstract Tandem two-pore potassium channels (K2Ps) have
widespread expression in the central nervous system and
periphery where they contribute to background membrane
conductance. Some general anaesthetics promote the opening
of some of these channels, enhancing potassium currents and
thus producing a reduction in neuronal excitability that con-
tributes to the transition to unconsciousness. Similarly, these
channels may be recruited during the normal sleep-wake cycle
as downstream effectors of wake-promoting neurotransmitters
such as noradrenaline, histamine and acetylcholine. These
transmitters promote K2P channel closure and thus an increase
in neuronal excitability. Our understanding of the roles of
these channels in sleep and anaesthesia has been largely
informed by the study of mouse K2P knockout lines and what
is currently predicted by in vitro electrophysiology and chan-
nel structure and gating.
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Abbreviations
CNS Central nervous system
GPCR G-protein-coupled receptor
HCN Hyperpolarisation-activated cyclic nucleotide-
gated channels
K2P or
KCNK
Tandem two-pore potassium channel
KO Knockout mouse model
NREMS Non-rapid eye movement sleep
REMS Rapid eye movement sleep
SSRI Selective serotonin reuptake inhibitor
TWIK Tandem of P-domains weak inward rectifying
K+ channel (TWIK-1 (KCNK1), TWIK-2
(KCNK6), TWIK-3 (KCNK7))
TREK TWIK-related K+ channel (TREK-1 (KCNK2),
TREK-2 (KCNK10))
TASK TWIK-related acid-sensitive K+ channel
(TASK-1 (KCNK3), TASK-3 (KCNK9),
TASK-5 (KCNK15))
TRAAK TWIK-related arachidonic acid-activated K+
channel (KCNK4)
TALK TWIK-related alkaline-sensitive K+ channel
(TALK-1 (KCNK16), TALK-2 (KCNK17))
THIK TWIK-related halothane-inhibited K+ channel
(THIK-1 (KCNK13), THIK-2 (KCNK12))
TRESK TWIK-related spinal cord K+ channel
(KCNK18)
K2P channels, sleep and anaesthesia
The contribution of tandem two-pore potassium channels
(K2Ps) to background potassium membrane conductance,
coupled with their sensitivity to certain anaesthetics, suggests
that they may play a role in the effects of anaesthetics on the
mammalian conscious state, and by extension, to the mecha-
nisms behind sleep-wake alternation [30]. Franks and Lieb
[28] first identified a novel anaesthetic-activated potassium
current in the pond snail whichwas subsequently confirmed to
be mediated by a new class of channel, the K2P family, cloned
in mammals and snails some years later [4, 45, 50]. Our focus
will be on K2P channels with known anaesthetic sensitivities
that are expressed in the CNS. The mammalian K2P channel
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family has 15 mammalian members, separated into six sub-
families by structure and function [33, 41, 54], starting with
tandem of P-domains weak inward rectifying K+ channel
(TWIK) and the derivatively named TASK, TREK, THIK,
TRESK, TRAAK and TALK channels. Various K2P channel
subunits heterodimerise so, in addition to the electrophysio-
logical properties and anaesthetic sensitivities of the 15 chan-
nel homodimers, there are an unknown number of heterodi-
mers with distinct electrophysiological properties expressed
throughout the CNS.
Anaesthetics, particularly halogenated volatile anaesthetics
such as isoflurane and halothane, open various K2P channels.
What encourages us to think that this opening contributes to
the transition into unconsciousness is that mouse K2P knock-
outs (KOs) have altered behavioural responses after anaes-
thetics measured as reduction in locomotion, loss of righting
reflex (an animal surrogate measure of transition into uncon-
sciousness) and loss of limb withdrawal (deep surgical anaes-
thesia). Depending on the anaesthetic, this may be for several
reasons: first, the K2P channels are the direct target of anaes-
thetics; second, the channels are recruited downstream of
anaesthetic targets; or third, the absence of the channels during
development affects neuronal circuitry such that it is less
responsive to anaesthesia. With regard to their recruitment
downstream of anaesthetic targets, several K2P channels are
modulated by G-protein-coupled receptors (GPCRs) for his-
tamine, noradrenaline, acetylcholine and others that make it
probable that these channels mediate some of the effects of
these neurotransmitters during the sleep-wake cycle. There
may also be endogenous signalling molecules, as yet un-
known, that directly affect the activity of these channels.
Given, the widespread expression of K2P channels in the
CNS [78] and varied coupling to receptors, their distribution
may help identify which K2P members are involved in sleep
circuitry and anaesthesia. CNS expression of the K2P channel
family varies both between subtypes (for example, TALK-1
appears to be limited to the pancreas and is not seen in the
CNS) and also species [31]. There are some common themes,
however: TASK-1, TASK-2, TREK-1, TWIK-1, TRAAK and
THIK-1 are all strongly expressed in the cerebellum, hippo-
campal formation and dentate gyrus which suggest some
redundancy in function [2, 78] and may reflect
heterodimerisation in these regions [2]. Three of these chan-
nels (TREK-1, TASK-1 and TASK-3) are also co-expressed in
the adult rodent thalamus, particularly in the intralaminar and
reticular nuclei [2, 78], and there is evidence that their recruit-
ment there may be relevant to sleep-wake transitions.
K2P channels regulate diverse aspects of body physiology
Our understanding of how K2P channels are involved in sleep
and anaesthesia has relied heavily onmouse KO lines, and it is
worth mentioning that these lines display additional
phenotypes, reflecting the widespread role of K2P channels
in other processes, both in and beyond the brain. Examples
include the salt-sensitive hyperaldosteronism observed in
TASK-3 KO neonates and TASK-1 KO adults, reflecting the
role of these channels in normal kidney function [6, 38].
Meanwhile, out of TASK-3 and TASK-1 knockouts, only
TASK-1 KO mice have reduced blood pressure [63] and
diminished responses to hypoxia and moderate normoxic
hypercapnia [80]. Alterations such as these may interact with
sleep-wake behaviour and responses to anaesthetics; for ex-
ample, the attenuated ventilator response to hypoxia in TASK-
1 knockout mice [80] may affect respiratory responses to
anaesthesia and this should be borne in mind. Likewise,
human variation in K2P channels has already been implicated
in several pathologies. Arguably, the most severe example is
the single maternally imprinted mutation of TASK-3, which
results in Birk-Barel syndrome, characterised by mental retar-
dation and dysmorphism [7]. No other single human K2P
mutation has yet been linked to pathology, but single nucleo-
tide polymorphisms (SNPs) and splice variants of K2Ps that
have been associated with susceptibility to high blood pres-
sure [42], preterm labour [83] and migraine [48, 65] amongst
others. The relationships between K2P channels and human
sleep disorders or anaesthetic sensitivity have not yet been
investigated.
K2P channel involvement in pain and immobility
The loss of awareness produced by general anaesthetics is part
of the functional spectrum of clinical anaesthesia which in-
cludes analgesia, anxiolysis, amnesia and suppression of so-
matic responses to injury that can be motor, cardiovascular
and hormonal [71, 72]. Crucial to our discussion is evidence
that K2P channels play a role in several of these processes.
TREK-1, TRAAK [3, 40, 64], TRESK [48] and TASK-1 [52]
have all been implicated in the sensation of pain with knock-
out animals experiencing heightened pain sensitivity. Given
that anaesthetics tend to open these channels, this would
predict that the analgesic effect may involve activation of
K2P channels. TREK-1 in particular has been highlighted as
an important component of pain perception [62] and is
expressed in both small sensory neurons of the dorsal root
ganglion [3] and in regions like the thalamus that process
ascending nociceptive information. Likewise, these channels
have been implicated in the suppression of motor function
produced by anaesthetics [49, 75]. For example, TASK-like
currents have been observed in brainstem motoneurons; the
reduction in motoneuronal excitability that accompanies
anaesthetic-induced immobility has been attributed to these
currents [26, 76]. The involvement of K2P channels in anal-
gesia, muscle relaxation together with loss of awareness
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should be borne in mind when interpreting ‘loss of pain
reflexes’ or ‘immobility’ as an end point for knockout models.
Anaesthetic interaction with K2P channels
The study of the structure of K2P channels has demonstrated
that certain intracellular portions of the channel are necessary
for halogenated anaesthetics to produce an effect and has
given insight into how K2Ps are recruited in cell membrane
signalling via the activation of GPCRs. The name ‘tandem
two-pore’ comes from a feature that distinguishes K2Ps from
other potassium channels. Like all potassium channels, the
potassium-selective pore of K2Ps is composed of four-pore-
forming (P) domains which contain outer and inner transmem-
brane helices, a selectivity filter, a signature sequence and a
pore helix [60]. In other potassium channels, each channel
subunit is expressed with a single P-domain, so functional
channels assemble as tetramers. K2Ps, however, are expressed
as protomers with four transmembrane domains between
which sit two P-domains [60]. The assembly of a functional
channel, therefore, requires only a dimer. The N- and C-
termini of these dimers are intracellular, and there is an addi-
tional feature unique to this member of the potassium channel
superfamily: the extended ~55 amino acid extracellular loop
between transmembrane domains 1 and 2. In the resolved
TWIK-1 and TRAAK channel structures, these loops (which
are actually two helices) form an ‘A-frame’ cap directly above
the pore selectivity filter [12, 60]. This cap is far enough from
the pore that it allows access to potassium ions, but its pres-
ence may explain why K2P channels are resistant to certain
pore-blocking toxins that affect other potassium channels [12,
60]. This cap feature may be common to all members of the
K2P family, though its significance is unknown.
Several K2P channels are opened by anaesthetics. Two
notable exceptions are TWIK channels which appear insensi-
tive to anaesthetics and THIK channels which are closed by
high concentrations of halothane. The gating of all potassium
channels is thought to be mediated via two gating mechanisms
at distinct sites: an activation site near the intracellular en-
trance to the channel and an extracellular slow inactivation site
at the selectivity filter near the extracellular side [55]. Consis-
tent with this, TASK channel activation by halogenated an-
aesthetics requires amino acid 159 located on the intracellular
side of the transmembrane domain 3 [4, 18]. In addition to
this, a six-amino-acid region between transmembrane domain
4 and the C-terminus has also been identified as necessary for
TASK channel responses to halogenated anaesthetics [4, 77,
81]. It is unclear whether these six amino acids are directly
involved in the activation gate via which anaesthetics open
TASK channels or if they are in a site necessary for transduc-
tion of the binding signal to the gate [55]. Similarly, the C-
terminal domain and site Glu306 is important for anaesthetic
effects on TREK-1 [36, 68], although again, this does not
confirm that this is where anaesthetics bind. How anaesthetics
activate or inactivate other members of K2P channels is cur-
rently not fully understood. However, it may be relevant that
the two K2P members not opened by anaesthetics, TWIK and
THIK, lack conserved glycine residues found in other K2P
members and instead have a larger hydrophobic region. These
glycine residues in transmembrane domain 2 have been pro-
posed as a hinge for the activating gate in K2Ps and inwardly
rectifying potassium channels [16]. Different hinging mecha-
nisms for channel opening could distinguish those K2Ps that
are activated by anaesthetics and those that are not. In addi-
tion, the structure of the anaesthetic-binding region in K2Ps
may differ between species; while rodent and mollusk TASK
channels respond differently to anaesthetic enantiomers, hu-
man TASK channels do not [4, 44].
GPCRs and K2P channels
As previously mentioned, K2P channels are regulated by a
number of GPCRs, which are in turn involved in neuro-
transmitter systems associated with wakefulness, such as
acetylcholine, histamine, serotonin, glutamate and nor-
adrenaline [55]. Briefly, activation of Gαq proteins closes
TASK and TREK family channels and opens TRESK chan-
nels. Meanwhile, Gi proteins appear to open TREK chan-
nels while Gs proteins close TREK channels [55]. Several
wake-promoting transmitters such as histamine, acetylcho-
line, serotonin, glutamate and noradrenaline have receptors
that are G-protein coupled, and we can posit that activation
of these receptors while awake inhibits K2P channels in
distinct neuronal populations making these populations
more excitable. For example, all of the abovementioned
neurotransmitters have Gαq/11-coupled receptors in the
CNS and these proteins inhibit TASK and TREK channels,
which would subsequently lead to reduced potassium leak
currents and more membrane depolarisation [26], particu-
larly in the thalamus [20]. It is important to note that the
effector pathways involving K2P channels are likely to be
complicated because K2P channels can exist as heteromers.
TASK channels can exist both as functionally distinct
homodimers as well as TASK-1/TASK-3 heterodimers [1,
8, 11, 22, 43, 46], even in the same neuronal population. In
addition, heterodimerisation between K2P subfamilies
TWIK and TASK occurs in cerebellar granule neurons
[69], and heterodimerisation between THIK and TASK-1/
TASK-3 channels has been predicted in the same population
based on expression profiles [2]. Unravelling how these
combinations are regulated in situ will advance our
understanding of how K2Ps are involved in sleep-wake
signalling.
Pflugers Arch - Eur J Physiol (2015) 467:907–916 909
Role of K2P channels in sleep-wake regulation
K2P channel expression in regions associated with sleep-wake
transitions, such as the preoptic and superchiasmatic nuclei in
the hypothalamus and thalamic relay nuclei [78], suggest that
they may be involved in mechanisms promoting transition or
maintenance of the two states [21]. Thalamic relay neuronal
activity has two distinct activity states: <15 Hz burst activity
during sleep and ~40Hz tonic activity during wakefulness and
rapid eye movement sleep (REMS). During normal sleep-
wake activity, the switch between these two states is modu-
lated by the ascending brainstem, including cholinergic pro-
jections, and other ascending modulatory influences such as
serotonergic and glutamateric signalling [20]. These ascend-
ing inputs promote closure of K2P channels such as TASK-1/
TASK-3 and TREK; the subsequent depolarization of thalam-
ic neurons causes a switch to tonic firing associated with
wakefulness and REMS [10, 57–59]. This closure of K2Ps
during tonic firing appears to rely crucially on Gαq signalling
for the cholinergic input [13] and Gαq/11 signalling for sero-
tonergic and glutamatergic inputs [20, 26]. Conversely, open-
ing of K2Ps when the ascending input is withdrawn and their
functional antagonism with hyperpolarisation-activated cyclic
nucleotide gated channels (HCN) hyperpolarises
thalamocortical neurons and promotes burst firing patterns
associated with sleep [21, 82]. Reciprocal regulation of the
K2P and HCN current has likewise been observed with appli-
cation of anaesthetics such as halothane, isoflurane and
sevoflurane [14] which also promote hyperpolarisation of
the thalamus. Although the main focus has been on the open-
ing of TASK channels mediating this the anaesthetic-induced
change in thalamic membrane potential, Budde et al. note a
complex effect of halothane on the activation and inhibition of
various thalamic K2P channels such as TREK-1, TASK-1,
TASK-3 and THIK-2 which overall result in a switch to burst
firing [14]. Thalamocortical K2P channels are recruited both
during withdrawal of ascending input and after application of
anaesthesia but whether or not this recruitment is sufficient to
promote unconsciousness is controversial. The thalamus is
strongly implicated in the transitions between conscious and
unconscious states [82], but as we will discuss, none of the
K2P knockouts have so far displayed a compromised ability to
transit in and out of consciousness per se. Nevertheless, al-
tered sleep architecture and altered sensitivity to some anaes-
thetics in these animals suggest that thalamic K2P involvement
as well K2Ps in other regions are important.
So far, the only K2P channel mouse knockout with a
characterised sleep phenotype is the TASK-3-deficient line
[17, 34, 53, 67]. TASK-1 knockout mice were assessed for
sleep-wake behaviour and found to be indistinguishable from
controls [57].Whilst the proportion of time TASK-3 knockout
mice spend in wakefulness, non-rapid eye movement sleep
(NREMS) and REMS is similar to littermates, the distribution
of these states and their EEG quality varies. The REMS
episodes of TASK-3 mice show clear oscillatory fragmenta-
tion, and the mice have enhanced wake activity [67] as well as
an overall increase in the amplitude of sleep architecture [34,
53]. The locomotor activity within the wake period of these
mice is 2–3-fold increased above that of littermates [34, 53];
these results were replicated on independently generated
TASK-3 KO lines. The two key phenotypes that have
emerged from TASK-3 KOs, fragmented REMS and exag-
gerated wake activity, draw interesting parallels with the ef-
fects of drugs that suppress TASK-3 activity (Fig. 1). A
recently developed TASK-3 antagonist, compound 23, pro-
duces a significant elevation in wake simultaneous with
REMS and NREMS suppression in wild-type mice [17]; this
effect on the sleep-wake is similar to the TASK-3 KO pheno-
type (Fig. 1). The elevation in wakefulness in both these cases
may be mediated by disinhibition of cortico-thalamic process-
es, although why this effect is restricted to the light phase is
not clear (in the case of the antagonist this is simply the phase
in which the animals were dosed, so it may be a trivial
parallel). An alternative explanation for the wake-promoting
compound 23 effect and the TASK-3 knockout phenotype is
that the inhibition of TASK-1/TASK-3 channels in arousal
nuclei, such as the noradrenergic neurons in the locus
coeruleus [52, 75], increases the excitability of these arousal
nuclei and thereby promotes arousal. Given that locus
coeruleus firing is associated with alert and attentive behav-
iour [9], an overactive locus coeruleus may produce hyperac-
tivity in the ‘active’ nocturnal part of the sleep-wake cycle [34,
53]. Disinhibition of this arousal nucleus may also explain the
REMS phenotype of the TASK-3 mice. During normal
REMS, neurons in the locus coeruleus are silent [27], so an
aberrantly active locus coeruleus may interfere with mainte-
nance of this sleep state. Meanwhile, the REMS-suppressing
effect of the TASK-3 antagonist appears to be TASK-3-
specific because it cannot be replicated if the TASK-3 antag-
onist is administered to the TASK-3-deficient mice [17]; it is
controversial whether this is because the baseline REMS is
already impaired in these animals. Notably, the REMS-
suppressing effect of the antidepressant fluoxetine on wild-
type mice also cannot be replicated in TASK-3-deficient mice
[34]. The majority of antidepressants are also REMS-suppres-
sants, so it is interesting that the ‘REMS-impaired’ TASK-3-
deficient mice have an ‘antidepressant phenotype’ [34]. In
addition, TREK-1-deficient animals also show an antidepres-
sant phenotype [39, 56], although there is some dispute over
this [61]. Given that TREK-1 channels are robustly blocked
under most experimental conditions by the application of the
selective serotonin reuptake inhibitors (SSRIs) fluoxetine,
norfluoxetine, paroxetine and sipatrigin [24, 26, 84], it would
be interesting to see if TREK-1-deficient animals have im-
paired REMS and are also resistant to the REMS-suppressing
effects of fluoxetine. A recent review has questioned whether
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antidepressant suppression of REMS preferentially suppresses
some aspects of the sleep state (motor inhibition) over others
[25]. Studying the apparent resistance of K2P knockouts to
SSRI effects on REMS may shed light on this question.
Role of K2P channels in anaesthesia
General anaesthetics, whatever their various effects on anal-
gesia, amnesia and muscle relaxation, all have in common
their ability to suspend consciousness to some degree, depend-
ing on the drug dose administered. It is therefore crucial to
study their relationship with putative targets in whole animal
or clinical paradigms. The study of K2P channels and anaes-
thesia has, so far, therefore consisted of two necessary
branches of research: electrophysiology to determine which
anaesthetics directly open/close K2P channels, and the testing
of anaesthetics on K2P channel-deficient mouse strains to
determine whether the end point of hypnosis, sedation or loss
of pain reflexes can still achieved by the same dose of drug.
There is a third emerging branch that investigates indirect
modulation of K2P s during anaesthesia. For example, the
α2 adrenoceptor agonist and sedative drug dexmedetomidine
is not likely to open K2P channels, nor to act through Gq/11,
the G-protein associated with TASK channels, and yet TASK-
1-deficient mice are less sensitive to low sedative doses of
dexmedetomidine [52], suggesting an indirect mechanism of
action. Many K2P channels are also closed by local anaes-
thetics [47], but as these drugs do not suspend consciousness,
these interactions will not be discussed here.
Five of the six subfamilies of K2P channels are directly
sensitive to general anaesthetics, with the exception being
weak inward-rectifier TWIK-1 and TWIK-2 channels. Nota-
bly, TWIK-1 channels can still be closed by local anaesthetics
such as bupivacaine [31]. Because enhancement of back-
ground potassium current is a plausible mechanism for pro-
ducing anaesthesia [30, 44], THIK channels that are inhibited
by high concentrations of halothane are implausible candi-
dates for mediating anaesthetic mechanisms. In contrast,
based on in vivo mouse studies, TASK-1, TASK-3 and
TREK-1 channels are strong candidates for a likely role in
anaesthesia. Table 1 summarises the K2P channel knockout
lines and whether or not they have a reported change in
anaesthetic sensitivity. It is important to note that these assess-
ments were made in adult animals. Anaesthetic sensitivity
changes with rodent age, with adult animals having a much
lower minimum alveolar concentration for halogenated anaes-
thetics than juveniles [66]. This change in sensitivity may rely
in part on significant K2P channel CNS expression changes
CNS during development [2, 5]. The various studies use
different end points to assess different aspects of anaesthetic
effects on the conscious state: reduction in movement (a
surrogate measure of sedation), loss of righting reflex (a
surrogate measure of unconsciousness in animals) and loss
of paw or tail withdrawal to painful stimuli, which is normally
assumed to be unconsciousness coupled with immobility.
These different end points usually reflect the effects of in-
creasing doses of drug, e.g. low doses of halothane are seda-
tive and high doses cause loss of surgical reflexes, but do not
necessarily mean an escalation of the same mechanism or
recruitment of identical receptor populations in the CNS.
Despite the caveats of compensation, especially given that
K2P channels such as TASK-3 have been implicated in mouse
CNS development [5], and TASK-1 KO mice have upregu-
lated GABAA receptor function [51], K2P channel-deficient
mouse lines have yielded some interesting insights into an-
aesthetic processes. To date, there are mouse knockouts of
TASK-1, TASK-2, TASK-3, TREK-1, TRAAK, KCNK7 and
TRESK channels, as well as a TASK-1/TASK-3 double
knockout [1, 11, 15, 32, 39, 49, 80, 86]. In addition, there is
a TASK-1/TASK-3 channel knockout restricted to cholinergic
cells that is substantially less sensitive to isoflurane and
halothane-induced loss of righting reflex [49]. For anaesthesia
using halogenated anaesthetics (isoflurane, halothane,
sevoflurane, desflurane and chloroform), loss of specific K2P
channel expression generally results in a reduction, but not
complete loss, of anaesthetic sensitivity. However, even with-
in this class, there are differences. Halothane, for example,
requires TASK-1 and TASK-3 for loss of pain reflex and
TREK-1 for loss of righting reflex but does not require the
TRESK channel [15, 39, 49, 52, 53, 67]. On the other hand,
isoflurane-induced loss of pain reflex is diminished when both
TASK-1 and TASK-3 are absent [49] but it is unclear whether
single knockouts of TASK-3 channels have a diminished
sensitivity for pain reflex [49, 67] or if TASK-1 channels are
involved in isoflurane-induced loss of righting reflex [49, 67]
the way that TREK-1 channels appear to be [39]. Other classes
of anaesthetics have also been tested in K2P knockouts, al-
though not comprehensively. TASK-1mice are more sensitive
to GABAA receptor ligands and modulators propofol, pento-
barbital, and benzodiazepines as it takes them longer to re-
cover from the anaesthetised state [51]. This may be related to
the increased expression of GABAA receptors in these ani-
mals. No such extended recovery time was seen in TREK-1
channel knockouts, which recover the same as controls from
pentobarbital anaesthesia [39]. Propofol was tested on TASK-
3 knockouts, but recovery time was not reported, so while the
animals are certainly not less sensitive, it is not clear if they
would take longer to recover from the anaesthetic dose [53].
Opposing changes in sensitivity to halogenated and non-
halogenated anaesthetics such as those seen in TASK-1 chan-
nel knockouts highlights the importance of testing several
classes of anaesthetics on each knockout model because
generalising between channels or between anaesthetics is
problematic. Given that knockout lines of six of the eight
anaesthetic-sensitive K2P channels are available,
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comprehensive testing of propofol, pentobarbital, halothane,
isoflurane and others using a range of anaesthetic end points to
make the studies comparable might be informative. In any
case, the K2P knockout mouse studies have shown that K2P are
plausible targets for the actions of certain volatile and gaseous
agents; however, they are not the only targets and other
receptors and ion channels play a role—particularly certain
populations of GABAA receptors [29, 73, 79, 85].
In the absence of a comprehensive testing paradigm, there
are still published in vitro sensitivities that could be followed
up in vivo. So far, the translation from electrophysiology to
animal behaviour has been complex and likely to be affected
by compensatory mechanisms during development. For ex-
ample, TASK-2 channels are opened by clinically relevant
concentrations of isoflurane in vitro [35], but TASK-2 defi-
cient mice lose pain reflexes at the same dose of isoflurane
anaesthesia as wild-types [32]. It is possible that TASK-2-
deficient mice would show differences in loss of righting
reflex and reduction in locomotion, but these have not been
reported. Given the difficulty in predicting knockout sensitiv-
ity, it is crucial to test each drug by experiment. Another
question that can now be addressed following the develop-
ment of specific K2P channel blockers [17, 19, 56, 70] is
whether K2P channel blockers can, to some degree, reverse
general anaesthesia. As discussed above, TASK-3 channel
antagonists are wake-promoting in rodents [17], so it is at
least plausible that administration of such an agent during
anaesthesia would produce some degree of reversal. So far,
it appears that such agents do not reverse anaesthesia. In a
recent study of rat respiration during isoflurane anaesthesia,
administration of TASK antagonists, whilst stimulating
breathing, did not affect anaesthetic depth [19]. Quantified
support for this important observation is necessary, ideally
using the same anaesthetic end points as those in the mouse
knockout studies.
Conclusions and future directions
The focus on K2Ps as putative mediators of anaesthetics has
been to understand how these drugs produce a loss of con-
sciousness and painful sensation. There are two key motiva-
tions for this research: to understand how currently used
anaesthetics exert their effects and to identify novel targets
and develop better sedatives and anaesthetics. K2P channels
are likely to be necessary for the mechanism of action of
halogenated anaesthetics and may or may not mediate the
effects of some others. It is a curious phenomenon that in
K2P knockout mice loss of consciousness in response to one
drug can remain intact while others are less potent. Work on
these channels may also help us dissect out the pathways
responsible for desirable effects of anaesthesia from their side
effects. For example, TREK-1 may contribute to the neuro-
protective effect of the anaesthetic xenon [23, 37]. Conversely,
while TWIK-1 channels are so far not implicated in the
transition to unconsciousness in the CNS, theymay be recruit-
ed in phenobarbital-mediated hepatotoxicity [74] and as such
are undesirable targets. It may be no coincidence that the K2P
Fig. 1 Similarity between TASK-3 KO ‘sleep phenotype’mice and how
TASK-3 antagonist drugs affect the sleep-wake cycle in mice. a TASK-3
KO animals (red traces) have elevated wake in the light period with
concurrent reductions in both REMS and NREMS compared to wild-type
mice [67]. b Similarly, mice dosed with 100 mg/kg TASK-3 antagonist
‘compound 23’ (open circles) have elevated wake in the light period with
concurrent reductions in REMS and NREMS compared to mice dosed
with vehicle (closed circles) (modified from Coburn et al. [17])
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channels implicated in thalamocortical regulation, TASK and
TREK, are also those deficient in anaesthetic-resistant knock-
out mouse lines. The same channels are sensitive to REMS
manipulating fluoxetine, and the TASK-1 channel knockout is
less sensitive to sedative doses of dexmedetomidine, suggest-
ing it may also be a downstream effector of this distinct class
of anaesthetic. Thus, drugs that manipulate sleep architecture
such as fluoxetine and sedatives, such as low dose
dexmedetomidine, may have common K2P targets with gen-
eral anaesthetics.
A key question is whether K2P channels are recruited in
physiological sleep-wake regulation. With regard to REMS
and its pharmacological suppression, it is crucial to see if the
interaction between K2P channels and the REMS suppressor
fluoxetine is limited to this molecule or whether it is a com-
mon mechanism of many other REMS suppressants. Because
thalamocortical rhythms involve background potassium cur-
rents, K2P channels may be necessary for physiological sleep-
wake regulation [21]. Support for this comes from the altered
sleep phenotype and inability to sustain coherent REMS os-
cillations in TASK-3 knockout mice [67]. On the other hand,
sleep-wake transitions and time spent in arousal states are still
intact in TASK-3 knockouts, but this may be because other
thalamic (or non-thalamic) K2Ps can buffer the loss of TASK-
3. This emphasis on K2Ps in the thalamocortical circuits would
predict that channel knockouts of TASK-1 and TREK-1 and
Table 1 Sensitivity of K2P knockout mice to anaesthetics and sedatives
Channel KO Reduction in movement Loss of righting reflex Loss of pain reflex
TASK-3 dex—no change
hal (low dose)—↓
iso—no change
prop—no change
cyc—no change
etom—no change
hal—↓
iso—controversial; both no
change and ↓ have been shown
etom—no change
hal—↓
TASK-1 win—no change
zolp—no change
barb—no change
dex—↓
flur—↑
diaz—↑
gab—↑ (females only)
prop— (males only)
preg—↑ (males only)
iso—controversial. both no
change and ↓ have been shown
hal—no change
prop—↑ (extended duration of LORR)
barb—↑ (extended duration of LORR)
hal—↓
iso—no change
TASK-1/-3 hal (low dose) –↓ iso—no change
hal—↓
iso—↓
hal—↓
TASK-1/TASK-3 in cholinergic cells only hal (low dose) –↓ hal—no change iso—↓
hal—↓
TASK-2 Not tested Not tested iso—no change
hal—no change
desf—no change
TREK-1 Not tested iso—↓
hal—↓
sevo—↓
desf—↓
prop—no change
Not tested
TRESK Not tested Not tested iso—no change
hal—no change
desf—no change
sevo—no change*
KCNK7 Not tested Not tested iso—no change
hal—no change
desf—no change
Downwards arrows (↓) indicate that knockout animals were less affected by anaesthetic on that measure; conversely, upwards arrows (↑) indicate that
knockout animals were more affected than controls by anaesthetic on measure indicated
iso isoflurane, hal halothane, sevo sevoflurane, desf desflurane, chlor chloroform, prop propofol, etom etomidate, dex dexmedetomidine, cyc
cyclopropane, barb pentobarbital, win WIN55212-3, flur flurazepam, diaz diazepam, zolp zolpidem, preg pregnenalone, gab gaboxadol [15, 32, 36,
39, 49, 51–53, 86]
*Increased mortality after anaesthetic exposure
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possibly TREK-2 (all found in the thalamus) may have a
similar sleep phenotype to TASK-3 knockouts and that double
knockouts may produce a more severe phenotype. In addition,
this hypothesis also predicts that selective disruption of tha-
lamic K2P channels in vivo may produce a similar sleep
phenotype to that seen in the TASK-3 global knockout. In
comparison to the study of K2Ps and sleep, the study of K2P
channels in anaesthesia has advanced much further. The
emerging trend is that both TASK and TREK-1 channels are
both necessary for the full effects of halogenated anaesthetics,
but exactly which neuronal networks is only beginning to be
revealed [63]. Much still remains to be understood about the
roles these K2P channels play in the regulation of the natural
sleep-wake cycle.
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